Table 5.
Drug assays for tumour grafts or metastasis on a CAM platform.
| Drugs | Type of Tumour | Ref. |
|---|---|---|
| Hydrophobic derivatives of boswellic acid | PC-3 human prostate cancer | [111] |
| Monoclonal antibodies (anti-GD2) or Asn-Gly-Arg (NGR) peptides incorporated in liposomes | Neuroblastoma | [112] |
| Photosensitiser Ce6 | Bladder cancer | [113] |
| Bis(methoxyethyl)-di-n-propylporphycene (BEPPn) | RR 1022, epithelial cells from Rous sarcoma virus (RSV) | [114] |
| Photosensitising drug: methylene blue (MB) | Human malignant ovarian adenocarcinoma | [92] |
| Sema3C | Glioblastoma (U87 MG cells) | [115] |
| Streptokinase and gemcitabine | Lewis lung carcinoma | [103] |
| Neutralising antibody against protein A | Ovarian cancer | [116] |
| Doxorubicin in nanoparticles | Ovarian cancer | [53] |